Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
grade A 5.78 -2.03% -0.12
HROW closed down 2.03 percent on Wednesday, January 16, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical HROW trend table...

Date Alert Name Type % Chg
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Down 3 Days in a Row Weakness 0.00%
Jan 16 Down 4 Days in a Row Weakness 0.00%
Jan 15 Wide Bands Range Expansion -2.03%
Jan 15 Down 3 Days in a Row Weakness -2.03%
Jan 14 Wide Bands Range Expansion -2.86%
Jan 14 Overbought Stochastic Strength -2.86%
Jan 11 Upper Bollinger Band Walk Strength -4.46%
Jan 11 Inside Day Range Contraction -4.46%
Jan 11 Wide Bands Range Expansion -4.46%

Older signals for HROW ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Is HROW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.75
52 Week Low 1.45
Average Volume 438,747
200-Day Moving Average 3.2121
50-Day Moving Average 5.0854
20-Day Moving Average 5.48
10-Day Moving Average 5.895
Average True Range 0.5343
ADX 26.71
+DI 27.4402
-DI 19.2959
Chandelier Exit (Long, 3 ATRs ) 5.1471
Chandelier Exit (Short, 3 ATRs ) 6.1229
Upper Bollinger Band 6.501
Lower Bollinger Band 4.459
Percent B (%b) 0.65
BandWidth 37.262774
MACD Line 0.2876
MACD Signal Line 0.2784
MACD Histogram 0.0092
Fundamentals Value
Market Cap 115.97 Million
Num Shares 20.1 Million
EPS -0.81
Price-to-Earnings (P/E) Ratio -7.14
Price-to-Sales 1.39
Price-to-Book 4.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.53
Resistance 3 (R3) 6.52 6.26 6.41
Resistance 2 (R2) 6.26 6.07 6.27 6.36
Resistance 1 (R1) 6.02 5.95 5.89 6.03 6.32
Pivot Point 5.76 5.76 5.70 5.77 5.76
Support 1 (S1) 5.52 5.57 5.39 5.53 5.24
Support 2 (S2) 5.26 5.45 5.27 5.20
Support 3 (S3) 5.02 5.26 5.16
Support 4 (S4) 5.03